Hepatitis C screenings target high-risk populations

Hepatitis C screenings target high-risk populations hinh anh 1Kimberly Green, PATH’s programme director for HIV, tuberculosis, and non-communicable diseases in , speaks about a new initiative to increase access to HCV screening, diagnosis and treatment service for high-risk populations in HCM City (Photo courtesy of PATH)
 
HCM City (VNA) – People at risk of contracting hepatitis C virus (HCV) will be able to
access more convenient testing options and information through a new initiative
launched on February 1 in HCM City.

The increases access to HCV
screening, diagnosis and treatment for high-risk populations in the city.

Under the project, which will end in October, a total of 5,000 people at risk
will receive HCV information, and 2,500 clients will have HCV rapid diagnostic
testing, said Tran Thi Huong Lien, project coordinator.

The testing, which is available at community-led private
clinics, only requires a small amount of blood from the prick of a finger.

Ninety percent of HCV-reactive clients will receive confirmatory testing and
counselling on treatment options, Lien said.

Although up to 4 percent of the population in Vietnam are exposed to HCV, and
from 29 to more than 90 percent of populations with higher risk, such as
people who inject drugs and men who have sex with men, are exposed to HCV, only
a small proportion with the disease know they are infected, according to
Kimberly Green, PATH’s programme director for HIV, tuberculosis, and
non-communicable diseases in Vietnam.

Only a vastly reduced proportion of those diagnosed with HCV have access to and
complete entire course of treatment, she said.

This is despite the fact that HCV is curable and newer direct acting antivirals
are available that can treat HCV early in the course of disease and prevent
morbidity and early death due to cirrhosis, liver failure and cancer, she
added.

However, with rapid point-of-care testing, and lower-cost, direct-acting
antivirals that are pan-genotypic and can be used for all HCV genotypes, the
opportunity to identify, treat and work towards eliminating HCV are stronger
than ever before, Green said.

Similar to HIV, the HCV virus is spread through the blood or body fluids of an
infected person through unprotected sex or shared needles.
The project is being implemented by the HCM City Provincial AIDS Centre in
coordination with PATH, an international non-profit organisation, Gilead
Sciences, and in the city.-VNA 

VNA

Source: VietnamPlus

Leave a Reply

Your email address will not be published. Required fields are marked *

14 Vu Trong Phung, Thanh Xuan, Ha Noi.

Hotline

Hotline

+84365999115

Email Us at

Email Us at

info@herac.org

Contact

Contact

Herac